BRISTOL-MYERS SQUIBB’s PRAVACHOL (PRAVASTATIN) RECOMMENDED FOR APPROVAL BY FDA ADVISORY COMMITTEE; PANEL SUGGESTS PHASE IV STUDIES IN SPECIAL POPULATIONS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".